On the shores of Foggy Albion they plan to open a public hemp laboratory
-700x540.jpg)
The cardinal difference between the opening institution and similar research laboratories is that access to data obtained as a result of the work of the Center will be of a public nature.
One of the British companies specializing in research on the influence of cannabinoids on the human body, informed the media about the opening in the summer of 2017 of a research center designed to study the influence of various components of cannabis. According to the owners of the public hemp laboratory, the company is at the final stage of obtaining permissive documentation for cannabinoid research from the relevant state structures of England.
The cardinal difference between the opening institution and similar research laboratories is that access to data obtained as a result of the work of the Center will be of a public nature. Organizers of this kind of public research center are confident that a constant discussion between scientists and patients who need hemp preparations can create a new impetus for the development of pharmacological substances based on cannabis, and also improve the current drugs from hemp ingredients.
According to the organizers of the public hemp laboratory, the most valuable information about the work of the endocannabinoid system of the human body and the influence of cannabinoids can be seen as a result of research aimed at treating various ailments of the human body. Given the closed nature of this kind of research, the public hemp laboratory will be one of the first research centers specializing in open research and public clinical trials.
It is emphasized that one of the most important activities of the public laboratory will be the study of tetrahydrocannabinol (THC). This kind of interest on the part of researchers is based on the possibilities of treating various cancers of cannabinoids with this type of cannabinoid. In addition to the well-known properties of THC to remove pain and nausea accompanying chemotherapy, a number of medical centers in economically developed countries are carrying out research on the ability of tetrahydrocannabinol to inhibit the growth of cancer cells, inhibit their development and "trigger" the mechanisms of their gradual death.
Commentary of the Association "Ukrainian technical hemp"
At the moment, the only certified laboratory in the UK, specializing in research on cannabinoids and their use to treat the human body is GW Pharmaceuticals. The experiments of the employees of the above-mentioned company are not public and are conducted in a closed private laboratory. The declared ideas of the new licensed public laboratory on free access to information, as well as the technologies of hemp medicine among people in need of it, are comparable to open source software used in programming. How effective is this kind of method of studying the various components of cannabis for the further use of the acquired knowledge during treatment time will tell.
Information taken from the site http://tku.org.ua